Nightstar
AcquiredOxford, United Kingdom · Founded 2014 · $99.1M raised
- Headquarters
- Oxford
- Employees
- 51–200
- Founded
- 2014
- Business Model
- B2B
- Website
- nightstartx.com
- Total Funding
- $99.1M
- Last Round
- $45.0M Series CJun 2017
- Rounds
- 4
- Acquired by
- BiogenJun 2019 · $800.0M
About
Nightstar Therapeutics was an Oxford University spinout developing adeno-associated virus (AAV) gene therapies for inherited retinal diseases including choroideremia and retinitis pigmentosa. Founded in 2014, it completed a NASDAQ IPO in 2017 and was acquired by Biogen for approximately $800 million in June 2019.
Summary
Nightstar is a Biotech company based in Oxford, United Kingdom, founded in 2014. It has raised $99.1M in total across 4 rounds, most recently a $45.0M Series C round in Jun 2017.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jun 2019
Sign up to see all 6 rounds
Seed through Acquisition — per-round amounts, valuations, and who invested in each round.
Similar Companies
Specialty pharmaceutical company focused on addressing therapeutic needs in the fields of psychia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/nightstar"><img src="https://indexed.vc/api/badge/company/nightstar" alt="Nightstar on Indexed.vc" width="260" height="76" /></a>